M. Azria
Impact in
-
- Bone health and osteoporosis research
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
Papers in
-
- Bone health and osteoporosis research 15
- Bone and Joint Diseases 4
-
- Bone Metabolism and Diseases 11
- Co-authors
- Linda Mindeholm (6 shared papers)Stuart L. Silverman (2 shared papers)Melvin Olson (4 shared papers)Claus Christiansen (4 shared papers)P. Burckhardt (3 shared papers)Marc Engelhardt (2 shared papers)D. Manicourt (2 shared papers)C. H. Chesnut (1 shared paper)
- Journals
- Calcified Tissue International (6 papers)Bone (5 papers)Journal of Bone and Mineral Research (5 papers)Osteoporosis International (3 papers)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- SwitzerlandUnited StatesBelgium
In The Last Decade
M. Azria
41 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 96
- Orthopedics and Sports Medicine 434
- Pharmaceutical Science 170
- Rheumatology 252
- Cellular and Molecular Neuroscience 291
- Oncology 328
Countries citing papers authored by M. Azria
This map shows the geographic impact of M. Azria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Azria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Azria more than expected).
Fields of papers citing papers by M. Azria
This network shows the impact of papers produced by M. Azria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Azria. The network helps show where M. Azria may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Azria, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 180 | |
| 2 | 1984 | 165 | |
| 3 | 2005 | 130 | |
| 4 | 2006 | 116 | |
| 5 | 2005 | 96 | |
| 6 | 2004 | 82 | |
| 7 | 2010 | 82 | |
| 8 | 1987 | 80 | |
| 9 | 2002 | 73 | |
| 10 | 2002 | 66 | |
| 11 | 1999 | 50 | |
| 12 | 1989 | 48 | |
| 13 | 2002 | 48 | |
| 14 | 1989 | 42 | |
| 15 | 1996 | 39 | |
| 16 | 2012 | 37 | |
| 17 | 2009 | 36 | |
| 18 | 1992 | 36 | |
| 19 | Rationale for the potential use of calcitonin in osteoarthritis. | 2006 | 32 |
| 20 | 2005 | 31 |
About M. Azria
M. Azria is a scholar working on Orthopedics and Sports Medicine, Molecular Biology, Oncology, Physiology and Rheumatology, having authored 41 papers that have together received 1.6k indexed citations. Recurring topics across this work include Bone health and osteoporosis research (15 papers), Bone Metabolism and Diseases (11 papers), Osteoarthritis Treatment and Mechanisms (5 papers), Bone health and treatments (5 papers), Vitamin K Research Studies (4 papers), Pain Mechanisms and Treatments (4 papers), Bone and Joint Diseases (4 papers) and Neuropeptides and Animal Physiology (4 papers). The work is most often cited by research in Orthopedics and Sports Medicine (434 citations), Pharmaceutical Science (170 citations), Rheumatology (252 citations), Cellular and Molecular Neuroscience (291 citations) and Oncology (328 citations). M. Azria has collaborated with scholars based in Switzerland, United States and Belgium. Frequent co-authors include Linda Mindeholm, Stuart L. Silverman, Melvin Olson, Claus Christiansen, P. Burckhardt, Marc Engelhardt, D. Manicourt, C. H. Chesnut, M.A. Karsdal and Thierry Buclin. Their work appears in journals such as Calcified Tissue International, Bone, Journal of Bone and Mineral Research, Osteoporosis International and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.